A new study looked at COVID-19 related stressors and healthcare experiences, like facing discrimination, fear of perinatal infection, birth preparedness stress, telehealth prenatal care, disruptions to prenatal care, birth satisfaction, and duration of hospitalization and how these factors affected vaccination.
Hospital-onset CDI rates dropped by 6% in the first quarter of the program, which launched in 2016.
Higher ACE2 expression may explain why elderly people experience more severe COVID-19.
A study released tonight found 6 COVID-19 booster shots increased immunity for individuals who received a full 2 doses of the AstraZeneca or Pfizer-BioNTech vaccines.
The strategies address booster doses, travel, and rapid response.
Only 1 in 3 heterosexually active adults is aware of HIV PrEP, and this is even lower among Hispanic/Latinx men and women.
Study authors from the CDC found that girls in the sub-Saharan country of Namibia are at increased risk for HIV acquisition and also experience risk factors that make them eligible for HIV infection prevention programs.
The first Omicron COVID-19 case was discovered in California. The patient, who traveled from South Africa, has since recovered.
Even after it was confirmed safe, women living with HIV are neglecting to use the drug dolutegravir, potentially subjecting them to worse HIV treatment outcomes.
Rates of sustained viral suppression among people living with HIV were lower than expected, especially among children and adolescents.
After the intervention, more patients were correctly prescribed nPEP and more follow-up visits were recommended.
If the FDA authorizes molnupiravir based on the Antimicrobial Drugs Advisory Committee's recomendation, it would become the first oral COVID-19 treatment.
A recent study attributed COVID-19 morbidity and mortality disparities to “upstream issues” such as underlying conditions and lack of access to testing and care.
Pregnant women with sexually transmitted infections (STIs) were more likely to give birth prematurely.
As there is a lot of information regarding the Omicron variant, here is our latest slideshow to offer some insights on it.
Moderna and Pfizer's CEOs voice doubt on the current vaccines’ efficacy with the new variant, but are developing prophylaxis vaccines and treatment strategies to curtail the new strain.
While there is much still unknown about the Omicron variant, the World Health Organization says it poses “very high” risk due to its increased transmissibility.
Adding additional screening methods in combination with standard testing would increase diagnostic accuracy for tuberculosis infection among patients living with HIV.
Inhaled ciclesonide did not shorten duration of mild to moderate symptoms of COVID-19 in outpatients, but lessened hospitalizations.
The strain identified as B.1.1.529 is causing some travel restrictions from some African countries, and medical science is rushing to understand its potential impact on the global stage.
Individuals from European backgrounds had higher type 1 interferon pathway activity during early influenza infection than individuals with African genetic heritage.
COVID-19 vaccines are frequently tested in low- and middle-income countries, but they have experienced significant delays in vaccinating their own populations.
Analysis documents 9% rise in shots distributed after federal officials pushed for vaccination.
COVID-19 infection during pregnancy induced immune system rewiring in both mothers and their infants.
The FDA has approved patients 6 months and older to receive Seqirus's first-ever adjuvanted, cell-based influenza vaccine.
Disruptions to health care due to large-scale events, like that of the COVID-19 pandemic, can trickle into so much of what we need for public health, including routine vaccinations.
The federal agency's decision makes this the first CMV treatment for this patient population.
In its first real-world study, 2 doses of India’s BBV152 vaccine offered 50% protection against symptomatic COVID-19.
The Scynexis ibrexafungerp (Brexafemme) therapy cleared signs and symptoms of vaginal yeast infection in 73.9% of patients.
This infection has the ability to remain undetected and the potential to spread very quickly in long-term care facilities and hospitals.
